Identification of a CArG-independent region of the cysteine-rich protein 2 promoter that directs expression in the developing vasculature

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 4 54-4, 2003, Pages

  Chang, Yung Fu ^a,b   Wei, Jiao ^a   Liu, Xiaoli ^a   Chen, Yen Hsu ^a,b   Layne, Matthew D ^a   Yet, Shaw Fang ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Blood vessels; Serum response factor; Transgenic mice

Indexed keywords

CYSTEINE; CYSTEINE RICH PROTEIN 2; LIM PROTEIN; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CSRP2 GENE; DNA FLANKING REGION; GENE; GENE DELETION; GENE EXPRESSION; GENETIC TRANSCRIPTION; LACZ GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; REPORTER GENE; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

EID: 0141453829     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00165.2003     Document Type: Article

References (57)

1. Arber S and Caroni P. Specificity of single LIM motifs in targeting and LIM/LIM interactions in situ. Genes Dev 10: 289-300, 1996.
2. Arber S, Halder G, and Caroni P. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 79: 221-231, 1994.
3. Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard JC, Chien KR, and Caroni P. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88: 393-403, 1997.
4. Bach I. The LIM domain: regulation by association. Mech Dev 91: 5-17, 2000.
5. Belaguli NS, Zhou W, Trinh TH, Majesky MW, and Schwartz RJ. Dominant-negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets. Mol Cell Biol 19: 4582-4591, 1999.
6. Bermingham JR Jr, Shumas S, Whisenhunt T, Sirkowski EE, O'Connell S, Scherer SS, and Rosenfeld MG. Identification of genes that are downregulated in the absence of the POU domain transcription factor pou3f1 (Oct-6, Tst-1, SCIP) in sciatic nerve. J Neurosci 22: 10217-10231, 2002.
7. Chang DF, Belaguli NS, Iyer D, Roberts WB, Wu SP, Dong XR, Marx JG, Moore MS, Beckerle MC, Majesky MW, and Schwartz RJ. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev Cell 4: 107-118, 2003.
8. Chang PS, Li L, McAnally J, and Olson EN. Muscle specificity encoded by specific serum response factor-binding sites. J Biol Chem 276: 17206-17212, 2001.
9. Crawford AW, Pino JD, and Beckerle MC. Biochemical and molecular characterization of the chicken cysteine-rich protein, a developmentally regulated LIM-domain protein that is associated with the actin cytoskeleton. J Cell Biol 124: 117-127, 1994.
10. Dawid IB, Breen JJ, and Toyama R. LIM domains: multiple roles as adapters and functional modifiers in protein interactions. Trends Genet 14: 156-162, 1998.
11. Feuerstein R, Wang X, Song D, Cooke NE, and Liebhaber SA. The LIM/double zinc-finger motif functions as a protein dimerization domain. Proc Natl Acad Sci USA 91: 10655-10659, 1994.
12. Fire A. Histochemical techniques for locating Escherichia coli β-galactosidase activity in transgenic organisms. Genet Anal Tech Appl 9: 151-158, 1992.
13. Golsteyn RM, Beckerle MC, Koay T, and Friederich E. Structural and functional similarities between the human cytoskeletal protein zyxin and the ActA protein of Listeria monocytogenes. J Cell Sci 110: 1893-1906, 1997.
14. Grutz GG, Bucher K, Lavenir I, Larson T, Larson R, and Rabbitts TH. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J 17: 4594-4605, 1998.
15. Günther S, Alexander RW, Atkinson WJ, and Gimbrone MA. Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol 92: 289-298, 1982.
16. Henderson JR, Brown D, Richardson JA, Olson EN, and Beckerle MC. Expression of the gene encoding the LIM protein CRP2: a developmental profile. J Histochem Cytochem 50: 107-111, 2002.
17. Henderson JR, Macalma T, Brown D, Richardson JA, Olson EN, and Beckerle MC. The LIM protein, CRP1, is a smooth muscle marker. Dev Dyn 214: 229-238, 1999.
18. Hungerford JE and Little CD. Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J Vasc Res 36: 2-27, 1999.
19. Jain MK, Fujita KP, Hsieh CM, Endege WO, Sibinga NE, Yet SF, Kashiki S, Lee WS, Perrella MA, Haber E, and Lee ME. Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells. J Biol Chem 271: 10194-10199, 1996.
20. Jain MK, Kashiki S, Hsieh CM, Layne MD, Yet SF, Sibinga NE, Chin MT, Feinberg MW, Woo I, Maas RL, Haber E, and Lee ME. Embryonic expression suggests an important role for CRP2/SmLIM in the developing cardiovascular system. Circ Res 83: 980-985, 1998.
21. Kim S, Ip HS, Lu MM, Clendenin C, and Parmacek MS. A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineages. Mol Cell Biol 17: 2266-2278, 1997.
22. Kirby ML and Waldo KL. Neural crest and cardiovascular patterning. Circ Res 77: 211-215, 1995.
23. Laird PW, Zijderveld A, Linders K, Rudnicki MA, Jaenisch R, and Berns A. Simplified mammalian DNA isolation procedure. Nucleic Acids Res 19: 4293, 1991.
24. Layne MD, Yet SF, Maemura K, Hsieh CM, Liu X, Ith B, Lee ME, and Perrella MA. Characterization of the mouse aortic carboxypeptidase-like protein promoter reveals activity in differentiated and dedifferentiated vascular smooth muscle cells. Circ Res 90: 728-736, 2002.
25. Li L, Liu Z, Mercer B, Overbeek P, and Olson EN. Evidence for serum response factor-mediated regulatory networks governing SM22α transcription in smooth, skeletal, and cardiac muscle cells. Dev Biol 187: 311-321, 1997.
26. Li L, Miano JM, Cserjesi P, and Olson EN. SM22α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res 78: 188-195, 1996.
27. Li L, Miano MM, Mercer B, and Olson EN. Expression of the SM22α promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 132: 849-859, 1996.
28. Lilly B, Olson EN, and Beckerle MC. Identification of a CArG box-dependent enhancer within the cysteine-rich protein 1 gene that directs expression in arterial but not venous or visceral smooth muscle cells. Dev Biol 240: 531-547, 2001.
29. Louis HA, Pino JD, Schmeichel KL, Pomies P, and Beckerle MC. Comparison of three members of the cysteine-rich protein family reveals functional conservation and divergent patterns of gene expression. J Biol Chem 272: 27484-27491, 1997.
30. Mack CP and Owens GK. Regulation of smooth muscle α-actin expression in vivo is dependent on CArG elements within the 5′ and first intron promoter regions. Circ Res 84: 852-861, 1999.
31. Madsen CS, Hershey JC, Hautmann MB, White SL, and Owens GK. Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J Biol Chem 272: 6332-6340, 1997.
32. Madsen CS, Regan CP, Hungerford JE, White SL, Manabe I, and Owens GK. Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5′-flanking and first intronic DNA sequence. Circ Res 82: 908-917, 1998.
33. Manabe I and Owens GK. CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest 107: 823-834, 2001.
34. Manabe I and Owens GK. The smooth muscle myosin heavy chain gene exhibits smooth muscle subtype selective modular regulation in vivo. J Biol Chem 276: 39076-39087, 2001.
35. Miano JM, Carlson MJ, Spencer JA, and Misra RP. Serum response factor-dependent regulation of the smooth muscle calponin gene. J Biol Chem 275: 9814-9822, 2000.
36. Mikawa T and Gourdie RG. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol 174: 221-232, 1996.
37. Moessler H, Mericskay M, Li Z, Nagl S, Paulin D, and Small JV. The SM 22 promoter directs tissue-specific expression in arterial but not in venous or visceral smooth muscle cells in transgenic mice. Development 122: 2415-2245, 1996.
38. Owens GK. Molecular control of vascular smooth muscle cell differentiation. Acta Physiol Scand 164: 623-635, 1998.
39. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 75: 487-517, 1995.
40. Parmacek MS. Transcriptional programs regulating vascular smooth muscle cell development and differentiation. Curr Top Dev Biol 51: 69-89, 2001.
41. Pashmforoush M, Pomies P, Peterson KL, Kubalak S, Ross J Jr, Hefti A, Aebi U, Beckerle MC, and Chien KR. Adult mice deficient in actinin-associated LIM-domain protein reveal a developmental pathway for right ventricular cardiomyopathy. Nat Med 7: 591-597, 2001.
42. Perez-Alvarado GC, Miles C, Michelsen JW, Louis HA, Winge DR, Beckerle MC, and Summers MF. Structure of the carboxy-terminal LIM domain from the cysteine rich protein CRP. Nat Struct Biol 1: 388-398, 1994.
43. Podlubnaya ZA, Tskhovrebova LA, Zaalishtsbvili MM, and Stefanenko GA. Electron microscopic study of α-actinin. J Mol Biol 92: 357-359, 1975.
44. Pomies P, Louis HA, and Beckerle MC. CRP1, a LIM domain protein implicated in muscle differentiation, interacts with α-actinin. J Cell Biol 139: 157-168, 1997.
45. 1 phase of the hepatocyte cell cycle. J Biol Chem 270: 18123-18132, 1995.
46. Regan CP, Adam PJ, Madsen CS, and Owens GK. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest 106: 1139-1147, 2000.
47. 1 type I collagen gene. Biochem J 280: 157-162, 1991.
48. Sadler I, Crawford AW, Michelsen JW, and Beckerle MC. Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J Cell Biol 119: 1573-1587, 1992.
49. Sanchez-Garcia I, Osada H, Forster A, and Rabbitts TH. The cysteine-rich LIM domains inhibit DNA binding by the associated homeodomain in Isl-1. EMBO J 12: 4243-4250, 1993.
50. Sanchez-Garcia I and Rabbitts TH. The LIM domain: a new structural motif found in zinc-finger-like proteins. Trends Genet 10: 315-320, 1994.
51. Schmeichel KL and Beckerle MC. The LIM domain is a modular protein-binding interface. Cell 79: 211-219, 1994.
52. Strobeck M, Kim S, Zhang JC, Clendenin C, Du KL, and Parmacek MS. Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells. J Biol Chem 276: 16418-16424, 2001.
53. Stronach BE, Siegrist SE, and Beckerle MC. Two muscle-specific LIM proteins in Drosophila. J Cell Biol 134: 1179-1195, 1996.
54. Thor S, Andersson SG, Tomlinson A, and Thomas JB. A LIM-homeodomain combinatorial code for motor-neuron pathway selection. Nature 397: 76-80, 1999.
55. Wang X, Lee G, Liebhaber SA, and Cooke NE. Human cysteine-rich protein. A member of the LIM/double-finger family displaying coordinate serum induction with c-myc. J Biol Chem 267: 9176-9184, 1992.
56. Weiskirchen R, Pino JD, Macalma T, Bister K, and Beckerle MC. The cysteine-rich protein family of highly related LIM domain proteins. J Biol Chem 270: 28946-28954, 1995.
57. Yet SF, Folta SC, Jain MK, Hsieh CM, Maemura K, Layne MD, Zhang D, Marria PB, Yoshizumi M, Chin MT, Perrella MA, and Lee ME. Molecular cloning, characterization, and promoter analysis of the mouse Crp2/SmLim gene. Preferential expression of its promoter in the vascular smooth muscle cells of transgenic mice. J Biol Chem 273: 10530-10537, 1998.